UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 74 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,000 | -93.2% | 10,530 | -28.6% | 0.00% | -100.0% |
| Q1 2021 | $88,000 | -43.2% | 14,749 | -50.2% | 0.00% | 0.0% |
| Q4 2020 | $155,000 | -44.6% | 29,600 | -8.3% | 0.00% | -80.0% |
| Q2 2020 | $280,000 | +22.8% | 32,279 | -17.8% | 0.01% | -16.7% |
| Q1 2020 | $228,000 | -42.3% | 39,245 | -28.3% | 0.01% | +200.0% |
| Q4 2019 | $395,000 | +381.7% | 54,733 | +309.6% | 0.00% | +100.0% |
| Q3 2019 | $82,000 | – | 13,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |